Introduction This study was performed to compare the efficacy and safety of PreserFlo MicroShunt (PMS) implantation with mitomycin C (MMC) applied by sub-tenon injection versus conventional application by MMC-soaked sponges. Methods This retrospective, 1-year cohort study included 100 eyes of 100 patients with glaucoma who underwent PMS implantation with MMC (0.4 mg/ml) delivered either by sub-tenon injection (50 eyes) or via soaked sponges (50 eyes). The primary outcome measure at 1 year was intraocular pressure (IOP) reduction, with complete success defined as an IOP reduction of ≥ 20% and achieving a target IOP of ≤ 21 or 18 mmHg without the use of medication. Secondary outcomes, including corneal endothelial cell density (CECD) loss, the number of medications, and complications, were assessed and compared between the groups. Results Sustained reductions in mean IOP were observed in both groups over the 1-year follow-up, with no significant differences between the groups. The complete success rate, with a target IOP of ≤ 21 mmHg after 1 year, was 19.3% in the sponge group and 26.4% in the injection group. The qualified success rate was 59.0% and 87.4% in the sponge and injection groups, respectively. A longer survival rate was observed in the injection group than in the sponge group when IOP was below 21 mmHg. The mean CECD significantly decreased (P < 0.01) from baseline to each postoperative follow-up time point in both groups. At 1 year postoperatively, the percentage of total CECD loss was 8.1% in the sponge group and 8.0% in the injection group. However, no significant differences in mean CECD values, the number of medications, or adverse events were found between the groups. Conclusions PMS implantation with sub-tenon injection of MMC was comparable in terms of efficacy and safety to traditional MMC delivery via soaked sponges. However, the injection group demonstrated a significantly higher success rate than the sponge group.
Eye diseases, which often lead to severe vision loss, can be prevented, reversed, or slowed down, if diagnosed early. The demand for accurate and timely diagnosis has stimulated the exploration of innovative diagnostic techniques, including the connection of deep learning with smartphone applications to analyze eye images. This review explores how smartphone-based systems transform diagnostic processes using built-in cameras, computational resources, and deep learning models to provide inexpensive solutions for early detection on a massive scale.We provide a comprehensive analysis of recent advances in smartphone deep learning applications using eye imaging diagnostic techniques in ophthalmology, highlighting the key application areas and examining the underlying methodologies, hardware, and software solutions used, as well as their clinical implications.We describe 26 complete diagnostic solutions consisting of the smartphone application with the ability to capture images using the smartphone and the accessible deep learning model, supplemented with 48 partial solutions. The aim of this review is to present an overview of current solutions and provide a comprehensive view of future directions for technicians and ophthalmologists in this emerging interdisciplinary research field.
Class imbalance in diabetic retinopathy (DR) datasets, particularly the underrepresentation of advanced stages such as proliferative DR, limits classifier performance and necessitates specialized augmentation strategies. This study presents a data augmentation approach using StyleGAN2-ADAto generate stage-specific synthetic fundus images. Unlike conditional approaches requiring labels or segmentation masks, our method trains separate unconditional models for each DR severity stage, producing anatomically realistic images while preserving pathological characteristics. We propose a comprehensive evaluation framework comprising three components: quantitative assessment using distribution-based metrics (FID, KID, IS) and nearest-neighbor-based metrics (NN-SSIM, NN-PSNR); task-based evaluation through DR classification experiments with ConvNeXt Tiny, MobileNet V3 Small, and Xception architectures; and expert validation by three ophthalmologists assessing clinical plausibility. Classification experiments demonstrated improvements in overall accuracy, with ConvNeXt Tiny achieving 73.48% accuracy (+1.82% over baseline) when combining synthetic and classical augmentation. Inter-rater reliability analysis (κ = 0.723 between two evaluators) confirmed the clinical realism of generated images. Our unconditional StyleGAN2-ADA approach provides a scalable, mask-free augmentation solution addressing class imbalance in fundus imaging datasets, potentially enhancing DR screening systems in resource-constrained clinical settings.
24 October 2026 in Biomedical Signal Processing and Control
A porcine xenograft was successfully used as a temporary biological cover for severe xanthogranulomatous defects of the eyelid. Xenografts were successfully used in both upper and lower eyelid reconstructions. Other surgical techniques or the use of full-thickness skin grafts were not possible.